Denmark · Biotechnology startup
Denmark · ADCendo
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.
Funding reportedLast round: Series A
Follow ADCendo and see its new rounds in your feed.Start following
What company datasets say ADCendo raised
Funding, as reported
Reported in all114.6Min the source's currency
Rounds5
Last roundSeries A
Last round dateMay 2024
Investors listed8
Biotechnology in Denmark
Startups like it
Is this your company?
Add your raise, your deck and your story, and put ADCendo in front of investors. Or tell us what we have wrong.